Bioproduction Congress 2022

CMC Readiness to accelerate
biotherapeutics for patients

Scientific Advisory Board

Alain Beck

Alain Beck
Senior Director, Biologics CMC & developability
Centre d’Immunologie Pierre Fabre

Centre d’Immunologie Pierre Fabre
Roland Beliard

Roland Beliard
CEO
LFB Biomanufacturing

LFB Biomanufacturing
Nicola Beltraminelli

Nicola Beltraminelli
Chief Development Officer
Innate Pharma

Innate Pharma
Hervé Broly

Hervé Broly
Executive CMC Consultant for Biologics
Merck

Merck
Cédric Charretier

Cédric Charretier
Global Head Vaccine Drug Substance Development, Vaccine CMC Development Supply
Sanofi

Sanofi
Olivier Cochet

Olivier Cochet
Head of Biotech Developpment and Supply
Debiopharm

Debiopharm
Arnaud Delobel

Arnaud Delobel
R&D Director Strategy & Innovation
Quality Assistance

Quality Assistance
Sophie Derenne

Sophie Derenne
Head of the Department Analysis and Market Development
Etablissement Français du Sang (EFS)

Etablissement Français du Sang (EFS)
Annick Gervais

Annick Gervais
Head of Analytical Development Sciences
UCB Pharma

UCB Pharma
Elodie Guidat

Elodie Guidat
MSAT Site Lead Vitry & USP Head Vitry/Lyon
Sanofi

Sanofi
Michaël Lanero Fidalgo

Michaël Lanero Fidalgo
Chief Operating Officer
TreeFrog Therapeutics

TreeFrog Therapeutics
Laszlo Parta

Laszlo Parta
Director USP Development
Celonic

Celonic
Nicolas Rousseau

Nicolas Rousseau
Chief Operating Officer & Co-founder
EverZom

EverZom
Bernard Vanhove

Bernard Vanhove
Chief Development Officer
Egle Therapeutics

Egle Therapeutics
Francisca Gouveia

Francisca Gouveia
Innovation, data & digital lead
Novartis

Novartis
Pierre Heimendinger

Pierre Heimendinger
Vice President Pharmaceutical Operations
Sangamo Therapeutics

Sangamo

Organization contact